The JAK2 V617F Mutation Identifies a Subgroup of MDS Patients With Isolated Deletion 5q and a Proliferative Bone Marrow

Leukemia. 2006 Jul;20(7):1319-21. doi: 10.1038/sj.leu.2404215. Epub 2006 Apr 13.

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bone Marrow / pathology
  • Cell Division
  • Chromosome Deletion
  • Chromosomes, Human, Pair 5*
  • Female
  • Genetic Markers*
  • Humans
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / classification
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / pathology*
  • Point Mutation

Substances

  • Genetic Markers
  • JAK2 protein, human
  • Janus Kinase 2